Clinical Development: PHASES I - III

REVNUU

Switzerland

Service ID:

EP326S2
Service description

As innovators advance through clinical trials, their mission is to prove efficacy, engage key opinion leaders (KOLs), and secure later-stage funding or partnerships. The communications challenge is to articulate complex clinical progress with scientific rigor and strategic intent, building a foundation for future commercial success. Revnuu provides the integrated marketing and communications strategy essential for this critical stage. We ensure the brand and data tell a compelling, consistent story to investors, regulatory bodies, and future partners. Our tailored services include:  a) Brand Audit and Identity: Refining or establishing a professional brand identity that reflects your scientific maturity and market potential. b) Strategic Messaging and Pitch Deck Development: Crafting a powerful investment narrative and materials for Series B+ rounds and BD discussions. c) Website and Digital Presence: Designing an authoritative website that serves as a central hub for data, team credibility, and partnership opportunities. d) Data Communication and KOL Engagement: Planning for the impactful release of clinical data and building relationships with leading medical experts. e) Social Media Communication Plan: A targeted strategy to build scientific community awareness and support recruitment or advocacy efforts. We transform clinical milestones into a cohesive brand narrative that builds credibility, attracts capital, and paves the way for market entry. A targeted communication service for EIC beneficiaries advancing through clinical trials. These services help to ensure clinical progress is articulated to engage key opinion leaders, regulators, and later-stage investors. The key deliverables are narrative creation and refinement for the pitch deck, communication packages (internal communication assets and external communication assets - presentation slides, business cards, investor kit, event kit, brochure, technical data sheet, etc.), final white paper creation for public use, website foundation (showcasing the project, product, and applications), and marketing strategy and roadmap.

Sector
Biotechnology
Health and medical care
Pharmaceuticals
Technology Readiness Level
TRL 2 – Technology concept formulated
TRL 3 – Experimental proof of concept
TRL 4 – Technology validated in lab
TRL 5 – Technology validated in relevant environment
TRL 6 – Technology demonstrated in relevant environment
TRL 7 – System prototype demonstration in operational environment
TRL 8 – System complete and qualified
TRL 9 – Actual system proven in operational environment
Financial requirements

€64,475.

i

Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!

i

Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project webiste.

Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.